{"id":"https://openalex.org/W4389029520","doi":"https://doi.org/10.1093/ofid/ofad500.445","title":"375. The Effect of Inhaled Interferon Beta-1a (SNG001) Treatment Compared to Placebo on Lung Antiviral Biomarkers and Viral Clearance in Chronic Obstructive Pulmonary Disease (COPD) Patients With Respiratory Virus Infections","display_name":"375. The Effect of Inhaled Interferon Beta-1a (SNG001) Treatment Compared to Placebo on Lung Antiviral Biomarkers and Viral Clearance in Chronic Obstructive Pulmonary Disease (COPD) Patients With Respiratory Virus Infections","publication_year":2023,"publication_date":"2023-11-27","ids":{"openalex":"https://openalex.org/W4389029520","doi":"https://doi.org/10.1093/ofid/ofad500.445"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofad500.445","doi":"https://doi.org/10.1093/ofid/ofad500.445","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofad500.445","pdf_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.445/53775116/ofad500.445.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.445/53775116/ofad500.445.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112095974","display_name":"Phillip Monk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146824","display_name":"Synairgen (United Kingdom)","ror":"https://ror.org/04h6ep125","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146824"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Phillip D Monk","raw_affiliation_strings":["Synairgen Research Ltd , Southampton, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synairgen Research Ltd , Southampton, England , United Kingdom","institution_ids":["https://openalex.org/I4210146824"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078857778","display_name":"Jody L. Brookes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146824","display_name":"Synairgen (United Kingdom)","ror":"https://ror.org/04h6ep125","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146824"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jody L Brookes","raw_affiliation_strings":["Synairgen Research Ltd , Southampton, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synairgen Research Ltd , Southampton, England , United Kingdom","institution_ids":["https://openalex.org/I4210146824"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038499084","display_name":"Victoria J. Tear","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146824","display_name":"Synairgen (United Kingdom)","ror":"https://ror.org/04h6ep125","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146824"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Victoria J Tear","raw_affiliation_strings":["Synairgen Research Limited , Southampton, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synairgen Research Limited , Southampton, England , United Kingdom","institution_ids":["https://openalex.org/I4210146824"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045434240","display_name":"Toby N. Batten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toby Batten","raw_affiliation_strings":["Veramed Ltd , Twickenham, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veramed Ltd , Twickenham, England , United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009471051","display_name":"Clare Newall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clare Newall","raw_affiliation_strings":["Veramed Ltd , Twickenham, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veramed Ltd , Twickenham, England , United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089967962","display_name":"Marcin Mankowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcin Mankowski","raw_affiliation_strings":["tranScrip , Wokingham, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"tranScrip , Wokingham, England , United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037385250","display_name":"Michael George Crooks","orcid":"https://orcid.org/0000-0001-6876-0258","observed_orcids":["https://orcid.org/0000-0001-6876-0258"]},"institutions":[{"id":"https://openalex.org/I191240316","display_name":"University of Hull","ror":"https://ror.org/04nkhwh30","country_code":"GB","type":"education","lineage":["https://openalex.org/I191240316"]},{"id":"https://openalex.org/I69768126","display_name":"Hull York Medical School","ror":"https://ror.org/0003e4m70","country_code":"GB","type":"education","lineage":["https://openalex.org/I69768126"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael G Crooks","raw_affiliation_strings":["Hull York Medical School, University of Hull , Hull, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull York Medical School, University of Hull , Hull, England , United Kingdom","institution_ids":["https://openalex.org/I191240316","https://openalex.org/I69768126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068917661","display_name":"Dave Singh","orcid":"https://orcid.org/0000-0001-8918-7075","observed_orcids":["https://orcid.org/0000-0001-8918-7075"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dave Singh","raw_affiliation_strings":["University of Manchester , Manchester, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Manchester , Manchester, England , United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076371917","display_name":"Rekha Chaudhuri","orcid":"https://orcid.org/0000-0001-8007-949X","observed_orcids":["https://orcid.org/0000-0001-8007-949X"]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rekha Chaudhuri","raw_affiliation_strings":["University of Glasgow , Glasgow, Scotland , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Glasgow , Glasgow, Scotland , United Kingdom","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078591853","display_name":"Kerry Lunn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146824","display_name":"Synairgen (United Kingdom)","ror":"https://ror.org/04h6ep125","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146824"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kerry Lunn","raw_affiliation_strings":["Synairgen , southampton, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synairgen , southampton, England , United Kingdom","institution_ids":["https://openalex.org/I4210146824"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108510943","display_name":"Sophie Reynolds","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146824","display_name":"Synairgen (United Kingdom)","ror":"https://ror.org/04h6ep125","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146824"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sophie Reynolds","raw_affiliation_strings":["Synairgen Research Ltd , Southampton, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synairgen Research Ltd , Southampton, England , United Kingdom","institution_ids":["https://openalex.org/I4210146824"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020002494","display_name":"Sarah Dudley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146824","display_name":"Synairgen (United Kingdom)","ror":"https://ror.org/04h6ep125","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146824"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Dudley","raw_affiliation_strings":["Synairgen Research Limited , Southampton, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synairgen Research Limited , Southampton, England , United Kingdom","institution_ids":["https://openalex.org/I4210146824"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021092203","display_name":"Felicity J. Gabbay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felicity Gabbay","raw_affiliation_strings":["Transcrip , Winnersh, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Transcrip , Winnersh, England , United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089020623","display_name":"Stephen T. Holgate","orcid":"https://orcid.org/0000-0003-2658-4617","observed_orcids":["https://orcid.org/0000-0003-2658-4617"]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen T Holgate","raw_affiliation_strings":["University of Southampton , Southampton, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southampton , Southampton, England , United Kingdom","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043576559","display_name":"Ratko Djukanovi\u0107","orcid":"https://orcid.org/0000-0001-6039-5612","observed_orcids":["https://orcid.org/0000-0001-6039-5612"]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ratko Djukanovic","raw_affiliation_strings":["Faculty of Medicine, University of Southampton , SOUTHAMPTON, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, University of Southampton , SOUTHAMPTON, England , United Kingdom","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069988933","display_name":"Tom M. A. Wilkinson","orcid":"https://orcid.org/0000-0003-1771-3851","observed_orcids":["https://orcid.org/0000-0003-1771-3851"]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tom Wilkinson","raw_affiliation_strings":["University of Southampton , Southampton, England , United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southampton , Southampton, England , United Kingdom","institution_ids":["https://openalex.org/I43439940"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3676,"currency":"USD","value_usd":3676},"apc_paid":{"value":3676,"currency":"USD","value_usd":3676},"fwci":0.3669,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.62602421,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"10","issue":"Supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9115999937057495,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9115999937057495,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.060100000351667404,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.013700000010430813,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9629999995231628},{"id":"https://openalex.org/keywords/respiratory-viral-infections","display_name":"respiratory viral infections","score":0.9570000171661377},{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.871999979019165},{"id":"https://openalex.org/keywords/interferon-stimulated-genes","display_name":"interferon-stimulated genes","score":0.9649999737739563},{"id":"https://openalex.org/keywords/mx1","display_name":"MX1","score":0.9800000190734863},{"id":"https://openalex.org/keywords/oas1","display_name":"OAS1","score":1.0},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":1.0},{"id":"https://openalex.org/keywords/viral-clearance","display_name":"viral clearance","score":0.875},{"id":"https://openalex.org/keywords/human-rhinovirus","display_name":"human rhinovirus","score":0.9129999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8597649931907654},{"id":"https://openalex.org/C2776301714","wikidata":"https://www.wikidata.org/wiki/Q259346","display_name":"Sputum","level":3,"score":0.7390776872634888},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.6937662363052368},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.5884196758270264},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5454819798469543},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5014700889587402},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.46577852964401245},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.4459640085697174},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4345777630805969},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.426031231880188},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4220902621746063},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3233761489391327},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2446998953819275},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1505003273487091},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.07468721270561218},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06163370609283447},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/ofid/ofad500.445","doi":"https://doi.org/10.1093/ofid/ofad500.445","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofad500.445","pdf_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.445/53775116/ofad500.445.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10678701","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10678701","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10678701/pdf/ofad500.445.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofad500.445","doi":"https://doi.org/10.1093/ofid/ofad500.445","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofad500.445","pdf_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.445/53775116/ofad500.445.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389029520.pdf","grobid_xml":"https://content.openalex.org/works/W4389029520.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4399117275","https://openalex.org/W2990847452","https://openalex.org/W6920921048","https://openalex.org/W2970451689","https://openalex.org/W4387980143","https://openalex.org/W4317928270","https://openalex.org/W3103598365","https://openalex.org/W4311745038","https://openalex.org/W4388443762","https://openalex.org/W4280514824"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Respiratory":[2],"viral":[3,78,107,172,277,335,349],"infections":[4],"(RVIs)":[5],"are":[6],"major":[7],"drivers":[8],"of":[9,39,42,63,84,133,158,254,271,286,300,341,361,457],"chronic":[10],"obstructive":[11],"pulmonary":[12],"disease":[13],"(COPD)":[14],"exacerbations.":[15],"Interferon":[16],"beta":[17],"(IFN-\u03b2)":[18],"is":[19,454],"key":[20],"in":[21,67,90,120,197,216,231,246,268,279],"host":[22,33],"defence":[23],"against":[24],"viruses":[25],"but":[26],"can":[27],"be":[28],"suppressed":[29],"by":[30,174,449],"virus":[31],"or":[32,114],"factors":[34],"locally":[35],"at":[36],"the":[37,85,217,256,269,284,338],"site":[38],"infection.":[40],"Inhalation":[41],"SNG001":[43,65,113,203,221,289,321],"(IFN-\u03b2-1a":[44],"nebuliser":[45],"solution)":[46],"aims":[47],"to":[48,112,206,224,295,298,309],"restore":[49],"lung":[50,73,159,171,323,350],"IFN-\u03b2":[51],"levels.":[52],"SG015":[53],"(NCT03570359)":[54],"was":[55,88,213,242,265],"a":[56,93,104,251,306,455],"randomized,":[57],"placebo-controlled":[58],"Phase":[59],"2":[60,83],"clinical":[61],"study":[62,86],"inhaled":[64],"conducted":[66,89,267],"COPD":[68,98,129],"patients.":[69],"Here":[70],"we":[71],"describe":[72],"antiviral":[74,160,324,345],"biomarker":[75,161,331],"and":[76,103,154,168,170,178,191,196,200,229,238,240,333,365],"sputum":[77,180,209,329],"clearance":[79],"data":[80],"from":[81],"Part":[82],"which":[87,453],"patients":[91,99,272,287,301],"with":[92,100,137,202,220,305],"confirmed":[94],"RVI.":[95],"Methods":[96],"109":[97],"worsening":[101,132],"symptoms":[102,135],"positive":[105],"respiratory":[106,134],"test":[108],"were":[109,144,184],"randomized":[110],"1:1":[111],"placebo":[115,225],"once-daily":[116],"for":[117,156,347],"14":[118],"days":[119,147,227,235],"two":[121],"Groups:":[122],"A":[123,199,262],"(no":[124],"moderate":[125],"exacerbation);":[126],"B":[127,201,233],"(moderate":[128],"exacerbation":[130],"[i.e.,acute":[131],"treated":[136],"antibiotics":[138],"and/or":[139],"oral":[140],"corticosteroids]).":[141],"Sputum":[142],"samples":[143],"collected":[145],"on":[146,187,226,234,311,368],"1,":[148],"4,":[149],"7,":[150,189,236],"10,":[151,230],"13,":[152,239],"17":[153],"28":[155],"analysis":[157,264],"responses":[162,332],"(interferon-stimulated":[163],"genes":[164],"(ISGs):":[165],"Mx1,":[166],"OAS1":[167,179],"CXCL10)":[169],"load":[173,278],"RT-qPCR.":[175],"Results":[176],"Mx1":[177],"cell":[181,210,330],"gene":[182,211],"expression":[183,212],"significantly":[185,214],"upregulated":[186,215,322],"day":[188],"10":[190,237],"13":[192],"(p<":[193],"0.05)":[194],"overall":[195,218],"Groups":[198],"treatment":[204,222,346],"compared":[205,223],"placebo.":[207],"CXCL10":[208],"population":[219],"7":[228,313],"Group":[232,247],"there":[241],"no":[243],"significant":[244],"difference":[245],"A.":[248],"Patients":[249],"had":[250,274,291],"broad":[252],"range":[253],"RVIs,":[255],"most":[257],"common":[258],"being":[259],"human":[260],"rhinovirus.":[261],"post-hoc":[263],"therefore":[266],"subgroup":[270],"who":[273,290],"detectable":[275,292],"rhinovirus":[276,293],"sputum.":[280],"By":[281],"Day":[282,312],"4":[283],"proportion":[285],"receiving":[288,302,316],"reduced":[294],"40.0%":[296],"(compared":[297],"94.7%":[299],"placebo;":[303,317],"p=0.052),":[304],"further":[307],"reduction":[308],"20.0%":[310],"(versus":[314],"89.5%":[315],"p=0.014).":[318],"Conclusion":[319],"Inhaled":[320],"defenses":[325],"as":[326,343],"assessed":[327],"using":[328],"accelerated":[334],"clearance,":[336],"supporting":[337],"proposed":[339],"mechanism":[340],"action":[342],"an":[344],"severe":[348],"infections.":[351],"Disclosures":[352],"Phillip":[353],"D.":[354],"Monk,":[355],"PhD,":[356,385,445,493,494],"Synairgen":[357,362,377,386,446,450,458,473],"Research":[358,363,370,378,387,451,474,478],"Plc:":[359,371,447,460,475,479],"Employee":[360],"Plc":[364],"has":[366],"options":[367,381],"shares|Synairgen":[369],"Stocks/Bonds":[372,389,461,480,490],"Jody":[373],"L.":[374],"Brookes,":[375],"BSc,":[376],"Ltd:":[379],"Share":[380],"Victoria":[382],"J.":[383],"Tear,":[384],"Ltd.:":[388],"Marcin":[390],"Mankowski,":[391],"MD":[392],"MFPM":[393],"(Dis),":[394],"Multiple":[395],"companies:":[396],"Advisor/Consultant|Synairgen:":[397,425,426,488,489,496],"Advisor/Consultant":[398,414,429],"Michael":[399],"G.":[400],"Crooks,":[401],"MBChB":[402],"(hons),":[403],"MD,":[404,417,432,472,483],"FRCP,":[405],"AstraZeneca:":[406,418,433],"Advisor/Consultant|AstraZeneca:":[407],"Grant/Research":[408,427,434,497],"Support|AstraZeneca:":[409,435],"Honoraria|Chiesi:":[410,436],"Advisor/Consultant|Chiesi:":[411,419],"Honoraria|Gilead:":[412],"Honoraria|Synairgen:":[413],"Dave":[415],"Singh,":[416],"Advisor/Consultant|gsk:":[420],"Advisor/Consultant|Novartis:":[421],"Advisor/Consultant|Orion:":[422],"Advisor/Consultant|Pulmatrix:":[423],"Advisor/Consultant|Sanofi:":[424,487],"Support|Therevance:":[428],"Rekha":[430],"Chaudhuri,":[431],"Honoraria|GSK:":[437],"Honoraria|Novartis:":[438],"Honoraria|Sanofi:":[439],"Honoraria|Teva:":[440],"Honoraria":[441,499],"Sarah":[442],"Dudley,":[443],"N/A,":[444],"Employed":[448],"Ltd":[452],"subsidiary":[456],"Plc|Synairgen":[459],"Felicity":[462],"Gabbay,":[463],"MbChb,":[464],"Synairgen:":[465,495],"Board":[466,476],"Member":[467],"Stephen":[468],"T.":[469],"Holgate,":[470],"FMedSci,":[471],"Member|Synairgen":[477],"Ratko":[481],"Djukanovic,":[482],"GlaxoSmithKline:":[484],"Advisor/Consultant|GlaxoSmithKline:":[485],"Honoraria|KyMab:":[486],"Tom":[491],"Wilkinson,":[492],"Support|Synairgen:":[498]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-11-27T00:00:00"}